Some renal transplanted patients exhibit a positive cytomegalovirus (CMV)-antigenemia (more than 5 cells) with or without CMV-polymerase chain reaction (PCR) positive results and without any clinical ...
HIV-positive women with CMV in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV to their infants. The research also ...
—These investigators explored associations among early-life and in utero infections and cytomegalovirus-positive acute lymphoblastic leukemia in children, with signs pointing to underlying immune ...
Please provide your email address to receive an email when new articles are posted on . Survival was decreased for cytomegalovirus-seronegative patients who received a hematopoietic allogeneic stem ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...
Please provide your email address to receive an email when new articles are posted on . U.S. data revealed that cytomegalovirus was independently associated with latent tuberculosis infection, and ...
Cytomegalovirus (CMV) represents a major cause of morbidity after allogeneic stem cell transplantation (allo-SCT). Using interferon-gamma-enzyme-linked immunospot (ELISPOT) assay and HLA-peptide ...
Interim data demonstrate that HB‑101 is well tolerated HB-101 elicits T cell and B cell responses in the target population Trial participants were blinded and randomized 2:1 to receive either HB‑101 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...
CMV remains an area of huge unmet medical need. Despite decades of research, no CMV vaccine has been approved to date, underscoring the importance of these new discoveries COPENHAGEN, Denmark, ...
Phase 2 study to confirm dose to be initiated in near term, with planned interim analysis through 3 months; Phase 3 study planning is underway CMV is the most common infectious cause of birth defects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results